Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?

Journal of Affective Disorders

Volumn 127, Issue 1-3, 2010, Pages 10-18

  Correa, R ^a   Akiskal, H ^a   Gilmer, W ^b   Nierenberg, A A ^c   Trivedi, M ^d   Zisook, S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Antidepressants (AD); Bipolar disorder (BD); Major depressive disorder (MDD); Treatment resistant depression (TRD)

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; PLACEBO; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

BIPOLAR DISORDER; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; HYPOMANIA; MAJOR DEPRESSION; MANIA; PRIORITY JOURNAL; RELAPSE; REVIEW;

ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; DRUG RESISTANCE; HUMANS; RISK FACTORS;

EID: 78149360952     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2010.06.036     Document Type: Review

References (59)

1. E. Aguglia, M. Casacchia, and G.B. Cassano Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression Int. Clin. Psychopharmacol. 8 3 1993 197 202
2. H.S. Akiskal The bipolar spectrum: new concepts in classification and diagnosis L. Grinspoon, Psychiatry Update The American Psychiatric Association Annual Review vol. II 1983 American Psychiatrics Association Press Washington D.C 192 271
3. H.S. Akiskal, and F. Benazzi Optimizing the detection of bipolar II disorder in out patient private practice: toward a systematization of clinical diagnostic wisdom J. Clin. Psychiatry 66 7 2005 914 921
4. H.S. Akiskal, and F. Benazzi Atypical depression: a variant of bipolar II or a bridge between unipolar and bipolar II? J. Affect. Disord. 84 2-3 2005 209 217
5. H.S. Akiskal, and F. Benazzi How best to identify a bipolar-related subtype among major depressive patients without spontaneous hypomania: superiority of age at onset criterion over recurrence and polarity? J. Affect. Disord. 107 1-3 2008 77 88
6. H.S. Akiskal, and G. Mallya Criteria for the "soft" bipolar spectrum: treatment implications Psychopharmacol. Bull. 23 1 1987 68 73
7. H.S. Akiskal, J.D. Maser, P.J. Zeller, J. Endicott, W. Coryell, M. Keller, M. Warshaw, P. Clayton, and F. Goodwin Switching from "unipolar" to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients Arch. Gen. Psychiatry 52 2 1995 114 123
8. H.S. Akiskal, M.L. Bourgeois, J. Angst, R. Post, H. Möller, and R. Hirschfeld Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders J. Affect. Disord. 59 Suppl.1 2000 S5 S30
9. J.D. Amsterdam, and J. Shults Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study Int. Clin. Psychopharmacol. 20 5 2005 257 264
10. J.D. Amsterdam, and J. Shults Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression-lack of manic induction J. Affect. Disord. 87 1 2005 121 130
11. J. Angst Switch from depression to mania - a record study over decades between 1920 and 1982 Psychopathology 18 2-3 1985 140 154
12. Y. Barak, R. Kimhi, and R. Weizman Is selectivity for serotonin uptake associated with a reduced emergence of manic episodes in depressed patients? Int. Clin. Psychopharmacol. 15 1 2000 53 56
13. F. Benazzi Antidepressant-associated hypomania in outpatient depression: a 203 - case study in private practice J. Affect. Disord. 46 1 1997 73 77
14. M.T. Berlim, and G. Turecki Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods Can. J. Psychiatry 52 1 2007 46 54
15. H.G. Birnbaum, L. Shi, E. Dial, E.F. Oster, P.E. Greenberg, and D.A. Mallett Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis J. Clin. Psychiatry 64 10 2003 1201 1209
16. A. Bocchetta, F. Bernardi, and C. Burrai A double-blind study of L-sulpiride versus amitriptyline in lithium mantained bipolar depressives Acta Psychiatr. Scand. 88 6 1993 434 439
17. S.E. Byrne, and A.J. Tothschild Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments J. Clin. Psychiatry 59 6 1998 279 288
18. B.J. Chun, and D.L. Dunner A review of antidepressant-induced hypomania in major depression: suggestions for DSM-V Bipolar Disord. 6 1 2004 32 42
19. B. Cohen, and R. Baldessarini Tolerance to therapeutic effects of antidepressants Am. J. Psychiatry 142 4 1985 489 490
20. W.H. Crown, S. Finkelstein, E.R. Berndt, D. Ling, A.W. Poret, A.J. Rush, and J.M. Russell The impact of treatment-resistant depression on health care utilization and costs J. Clin. Psychiatry 63 11 2002 963 971
21. S.N. Ghaemi Why antidepressants are not antidepressants: STEP-BD, STARD, and the return of neurotic depression Bipolar Disord. 10 2008 957 968
22. S.N. Ghaemi, J.Y. Ko, and F.K. Goodwin "Cade's disease" and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder Can. J. Psychiatry 47 2 2002 125 134
23. S.N. Ghaemi, D.J. Hsu, F. Soldani, and F.K. Goodwin Antidepressants in bipolar disorder: the case for caution Bipolar Disord. 5 6 2003 421 433
24. S.N. Ghaemi, K.J. Rosenquist, J.Y. Ko, C.F. Baldassano, N.J. Kontos, and R.J. Baldessarini Antidepressant treatment in bipolar versus unipolar depression Am. J. Psychiatry 161 1 2004 163 165
25. H.J. Gijsman, J.R. Geddes, J.M. Rendell, W.A. Nolen, and G.M. Goodwin Antidepressants for bipolar depression: a systematic review of randomized, controlled trials Am. J. Psychiatry 161 9 2004 1537 1547
26. J.F. Goldberg, and C.J. Truman Antidepressant-induced mania: an overview of current controversies Bipolar Disord. 5 6 2003 407 420
27. J. Himmelhoch, M.E. Thase, A.G. Mallinger, and P. Houck Tranylcypromine versus Imipramine in anergic bipolar depression Am. J. Psychiatry 148 7 1991 910 916
28. R.M. Hirschfeld, L. Lewis, and L.A. Vornik Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder J. Clin. Psychiatry 64 2 2003 161 174
29. G. Hurowitz, and M. Liebowitz Antidepressant-induced rapid cycling: six case report J. Clin. Psychopharmacol. 13 1 1993 52 55
30. T. Inoue, S. Nakagawa, Y. Kitaichi, T. Izumi, T. Tanaka, T. Masui, I. Kusumi, K. Denda, and T. Koyama Long-term outcome of antidepressant-refractory depression: the relevance of unrecognized bipolarity J. Affect. Disord. 95 1-3 2006 61 67
31. S.G. Kornstein, and R.K. Schneider Clinical features of treatment-resistant depression J. Clin. Psychiatry 62 16 2001 18 25
32. G.S. Leverich, L.L. Altshuler, M.A. Frye, T. Suppes, S.L. McElroy, P.E. Keck Jr., R.W. Kupka, K.D. Denicoff, W.A. Nolen, H. Grunze, M.I. Martinez, and R.M. Post Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers Am. J. Psychiatry 163 2 2006 232 239
33. E. Lin, W.J. Katon, M. VonKorff, J.E. Russo, G.E. Simon, T.M. Bush, C.M. Rutter, E.A. Walker, and E. Ludman Relapse of depression in primary care: rate and clinical predictors Arch. Fam. Med. 7 5 1998 443 449
34. J.D. Lish The national depressive and manic-depressive association (DMDA) survey of bipolar members J. Affect. Disord. 31 4 1994 281 294
35. J.A. Mattes Antidepressant-induced rapid cycling: another perspective Ann. Clin. Psychiatry 18 3 2006 195 199
36. J.S. McCombs, J. Ahn, T. Tencer, and L. Shi The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis J. Affect. Disord. 97 1-3 2007 171 179
37. R. Moldawsky Tolerance to antidepressants Am. J. Psychiatry 142 12 1985 1519
38. C.J. Murray, and A.D. Lopez Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study Lancet 349 9064 1997 1498 1504
39. C.B. Nemeroff, D.L. Evans, L. Gyulai, G.S. Sachs, C.L. Bowden, I.P. Gergel, R. Oakes, and C.D. Pitts Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression Am. J. Psychiatry 158 6 2001 906 912
40. G. Parker, and K. Parker Which antidepressants flick the switch? Aust. NZ J. Psychiatry 37 4 2003 464 468
41. G.B. Parker, G.S. Malhi, J.G. Crawford, and M.E. Thase Identifying "paradigm failures" contributing to treatment-resistant depression J. Affect. Disord. 87 2-3 2005 185 191
42. G. Parker, L. Tully, A. Olley, and D. Hadzi-Pavlovic SSRIs as mood stabilizers for bipolar II disorder? A proof of concept study J. Affect. Disord. 92 2-3 2006 205 214
43. M. Peet Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants Br. J. Psychiatry 164 4 1994 549 550
44. R.M. Post, and L.L. Altshuler Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline Br. J. Psychiatry 189 2006 124 131
45. R.M. Post, L.L. Altshuler, M.A. Frye, T. Suppes, A.J. Rush, P.E. Keck Jr., S.L. McElroy, K.D. Denicoff, G.S. Leverich, R. Kupka, and W.A. Nolen Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers Bipolar Disord. 3 5 2001 259 265
46. J.G. Rabkin, F.M. Quitkin, P. McGrath, W. Harrison, and E. Tricamo Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management J. Clin. Psychopharmacol. 5 1 1985 2 9
47. R.A. Remick, C. Froese, and F.D. Keller Common side effects associated with monoamine oxidase inhibitors Prog. Neuropsychopharmacol. Biol. Psychiatry 13 3-4 1989 497 504
48. A.J. Rush, M.H. Trivedi, S.R. Wisniewski, A.A. Nierenberg, J.W. Stewart, D. Warden, G. Niederehe, M.E. Thase, P.W. Lavori, B.D. Lebowitz, P.J. McGrath, J.F. Rosenbaum, H.A. Sackeim, D.J. Kupfer, J. Luther, and M. Fava Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report Am. J. Psychiatry 163 11 2006 1905 1917
49. G.S. Sachs, B. Lafer, A.L. Stoll, M. Banov, A.B. Thibault, M. Tohen, and J.F. Rosenbaum A double-blind trial of bupropion versus desipramine for bipolar depression J. Clin. Psychiatry 55 9 1994 391 393
50. G.S. Sachs, A.A. Nierenberg, J.R. Calabrese, L.B. Marangell, S.R. Wisniewski, L. Gyulai, E.S. Friedman, C.L. Bowden, M.D. Fossey, M.J. Ostacher, T.A. Ketter, J. Patel, P. Hauser, D. Rapport, J.M. Martinez, M.H. Allen, D.J. Miklowitz, M.W. Otto, E.B. Dennehy, and M.E. Thase Effectiveness of adjunctive antidepressant treatment for bipolar depression N Engl J. Med. 356 17 2007 1711 1722
51. V. Sharma, M. Khan, and A. Smith A closer look at treatment resistant depression: is it due to a bipolar diathesis? J. Affect. Disord. 84 2-3 2005 251 257
52. T. Silverstone Moclobemide vs. Imipramine in bipolar depression: a multicentre double-blind clinical trial Acta Psychiatr. Scand. 104 2 2001 104 109
53. L. Vedel Severity of depressive episodes according to ICD-10: prediction of risk of relapse and suicide Br. J. Psychiatry 184 2004 153 156
54. T. Wehr, and F. Goodwin Rapid cycling in manic-depressives induced by tricyclic antidepressants Arch. Gen. Psychiatry 36 5 1979 555 559
55. T.A. Wehr, and F.K. Goodwin Can antidepressants cause mania and worsen the course of affective illness? Am. J. Psychiatry 144 11 1987 1403 1411
56. T.A. Wehr, D.A. Sack, N.E. Rosenthal, and R.W. Cowdry Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients Am. J. Psychiatry 145 2 1988 179 184
57. B.I. Yerevanian, R.J. Koek, J. Mintz, and L. Shi Bipolar pharmacotherapy and suicidal behavior Part 2. The impact of antidepressants J. Affect. Disord. 103 1-33 2007 13 21
58. L.T. Young Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression Am. J. Psychiatry 157 1 2000 124 126
59. M. Zetin, G. Aden, and R. Moldawsky Tolerance to amoxapine antidepressant effects Clin. Ther. 5 6 1983 638 643